Gilead Sciences Inc
(GILD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,886,000 | 6,746,000 | 10,051,000 | 11,631,000 | 9,474,000 |
| Marketable Securities | 11,089,000 | 12,168,000 | 10,734,000 | 12,721,000 | 13,382,000 |
| Receivables | 3,913,000 | 3,194,000 | 3,907,000 | 3,582,000 | 3,315,000 |
| Inventories | 1,008,000 | 1,052,000 | 986,000 | 922,000 | 882,000 |
| TOTAL | $30,926,000 | $24,643,000 | $26,950,000 | $30,296,000 | $28,361,000 |
| Non-Current Assets | |||||
| PPE Net | 4,810,000 | 4,653,000 | 4,564,000 | 4,502,000 | 4,377,000 |
| Investments And Advances | 2,074,000 | 2,276,000 | 3,529,000 | 1,488,000 | 2,195,000 |
| Intangibles | 17,056,000 | 17,342,000 | 17,619,000 | 17,903,000 | 18,981,000 |
| Other Non-Current Assets | 6,012,000 | 7,020,000 | 7,079,000 | 7,438,000 | 5,232,000 |
| TOTAL | $29,952,000 | $31,291,000 | $32,791,000 | $31,331,000 | $30,785,000 |
| Total Assets | $60,878,000 | $55,934,000 | $59,741,000 | $61,627,000 | $59,146,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,498,000 | 2,999,000 | 1,999,000 | 2,499,000 | 2,498,000 |
| Accounts payable and accrued liabilities | 527,000 | 532,000 | 590,000 | 713,000 | 632,000 |
| Accrued Expenses | 3,343,000 | 3,337,000 | 3,457,000 | 3,473,000 | 3,652,000 |
| TOTAL | $9,509,000 | $10,564,000 | $8,879,000 | $9,759,000 | $9,567,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,878,000 | 22,121,000 | 22,098,000 | 23,103,000 | 22,991,000 |
| Other Non-Current Liabilities | 5,027,000 | 5,114,000 | 6,598,000 | 6,122,000 | 5,855,000 |
| TOTAL | $33,898,000 | $27,228,000 | $28,683,000 | $29,218,000 | $28,843,000 |
| Total Liabilities | $43,407,000 | $37,792,000 | $37,562,000 | $38,977,000 | $38,410,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,253,528 | 1,253,724 | 1,254,373 | 1,263,637 | 1,265,146 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 13,709,000 | 14,445,000 | 18,709,000 | 19,388,000 | 17,616,000 |
| Other shareholders' equity | 49,000 | 185,000 | 158,000 | 210,000 | 249,000 |
| TOTAL | $17,471,000 | $18,142,000 | $22,179,000 | $22,650,000 | $20,736,000 |
| Total Liabilities And Equity | $60,878,000 | $55,934,000 | $59,741,000 | $61,627,000 | $59,146,000 |